These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21688351)

  • 41. The impact of anti-TNFα therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015.
    Lund K; Larsen MD; Knudsen T; Kjeldsen J; Nielsen RG; Nørgård BM
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1077-1085. PubMed ID: 31579961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
    Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
    Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical features and treatment of inflammatory bowel disease in a low-incidence area: A hospital-based retrospective cohort study in Taiwan.
    Yen HH; Hsu TC; Chen MW; Su PY; Chen YY
    Medicine (Baltimore); 2021 Mar; 100(10):e25090. PubMed ID: 33725901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory bowel disease in African-American children living in Georgia.
    Ogunbi SO; Ransom JA; Sullivan K; Schoen BT; Gold BD
    J Pediatr; 1998 Jul; 133(1):103-7. PubMed ID: 9672520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does infliximab prevent colectomy in acute and chronic active ulcerative colitis?
    Dan-Nielsen S; Wewer V; Paerregaard A; Hansen LF; Nielsen RG; Lange A; Jakobsen C
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):768-72. PubMed ID: 24572593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.
    Papamichael K; Rivals-Lerebours O; Billiet T; Vande Casteele N; Gils A; Ferrante M; Van Assche G; Rutgeerts PJ; Mantzaris GJ; Peyrin-Biroulet L; Vermeire S
    J Crohns Colitis; 2016 Sep; 10(9):1015-23. PubMed ID: 27022161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.
    Magro F; Dias CC; Portela F; Miranda M; Fernandes S; Bernardo S; Ministro P; Lago P; Rosa I; Pita I; Correia L; Rodrigues PP;
    J Crohns Colitis; 2019 Mar; 13(4):401-409. PubMed ID: 30329032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
    Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent.
    Goodhand JR; Kamperidis N; Joshi NM; Wahed M; Koodun Y; Cantor EJ; Croft NM; Langmead FL; Lindsay JO; Rampton DS
    Aliment Pharmacol Ther; 2012 Apr; 35(8):929-40. PubMed ID: 22404452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study.
    Flasar MH; Johnson T; Roghmann MC; Cross RK
    Inflamm Bowel Dis; 2008 Jan; 14(1):13-9. PubMed ID: 17973305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
    Huang C; Haritunians T; Okou DT; Cutler DJ; Zwick ME; Taylor KD; Datta LW; Maranville JC; Liu Z; Ellis S; Chopra P; Alexander JS; Baldassano RN; Cross RK; Dassopoulos T; Dhere TA; Duerr RH; Hanson JS; Hou JK; Hussain SZ; Isaacs KL; Kachelries KE; Kader H; Kappelman MD; Katz J; Kellermayer R; Kirschner BS; Kuemmerle JF; Kumar A; Kwon JH; Lazarev M; Mannon P; Moulton DE; Osuntokun BO; Patel A; Rioux JD; Rotter JI; Saeed S; Scherl EJ; Silverberg MS; Silverman A; Targan SR; Valentine JF; Wang MH; Simpson CL; Bridges SL; Kimberly RP; Rich SS; Cho JH; Rienzo AD; Kao LWH; McGovern DPB; Brant SR; Kugathasan S
    Gastroenterology; 2015 Nov; 149(6):1575-1586. PubMed ID: 26278503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.
    Leborgne L; Cheneau E; Wolfram R; Pinnow EE; Canos DA; Pichard AD; Suddath WO; Satler LF; Lindsay J; Waksman R
    Am J Cardiol; 2004 Feb; 93(4):389-93. PubMed ID: 14969608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center.
    Bodiwala V; Marshall T; Das KM; Brant SR; Seril DN
    Inflamm Bowel Dis; 2020 Nov; 26(12):1869-1877. PubMed ID: 32144933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
    Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term course of ulcerative colitis in the prebiologic era. A retrospective study in a tertiary referral center.
    Margagnoni G; Fascì Spurio F; Feigusch L; Koch M; Papi C; Aratari A
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):275-83. PubMed ID: 25384806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.
    Bernstein CN; El-Gabalawy H; Sargent M; Landers C; Rawsthorne P; Elias B; Targan SR
    Can J Gastroenterol; 2011 May; 25(5):269-73. PubMed ID: 21647462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study.
    Bewtra M; Newcomb CW; Wu Q; Chen L; Xie F; Roy JA; Aarons CB; Osterman MT; Forde KA; Curtis JR; Lewis JD
    Ann Intern Med; 2015 Aug; 163(4):262-70. PubMed ID: 26168366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of race and ethnicity on inflammatory bowel disease.
    Basu D; Lopez I; Kulkarni A; Sellin JH
    Am J Gastroenterol; 2005 Oct; 100(10):2254-61. PubMed ID: 16181378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex Differences in Treatment Strategies Among Patients With Ulcerative Colitis: A Retrospective Cohort Analysis of Privately Insured Patients.
    Sceats LA; Morris AM; Bundorf MK; Park KT; Kin C
    Dis Colon Rectum; 2019 May; 62(5):586-594. PubMed ID: 30762599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic.
    Aghaian E; Choe JE; Lin S; Stamper RL
    Ophthalmology; 2004 Dec; 111(12):2211-9. PubMed ID: 15582076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.